-+ 0.00%
-+ 0.00%
-+ 0.00%

Usana Health Sciences Lowers FY2026 GAAP EPS Guidance from $(0.61) to $(0.90) vs $(0.61) Est

Benzinga·11/03/2026 21:24:03
Diffusion vocale
Usana Health Sciences (NYSE:USNA) lowers FY2026 GAAP EPS guidance from $(0.61) to $(0.90) vs $(0.61) analyst estimate..